Drug firm Zydus Cadila on Wednesday said it has commenced supplies of its Covid-19 vaccine ZyCoV-D to the central government. The company has initiated the supply as per the order placed by the gover...

India will offer Covid-19 vaccination to adolescents between 15 and 18 years and booster doses to healthcare and frontline workers, and people aged 60 or older who have co-morbidities, starting in Jan...

Zydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be administered to adults as of now under the government&...

Zydus Cadila's three-dose Covid vaccine ZyCoV-D is set to be included in the national anti-coronavirus inoculation programme this month with the Centre placing a purchase order with the Ahmedabad-...

Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on Sund...

With talks underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D, the pharma company is learnt to have proposed a price of Rs 1,900 for its three-do...

Drug firm Cadila Healthcare on Friday said it has entered into an agreement with Shilpa Medicare for the production of its COVID-19 vaccine, ZyCoV-D. The company has, "entered into a definitive ...

The country registered 42,909 new cases on Monday, taking the cumulative infection tally has risen to 32,737,939. A lot of states have gradually started resuming physical classes for studen...

The National Technical Advisory Group on Immunisation (NTAGI) will soon hold a meeting to devise a roadmap for introducing Zydus Cadila's Covid vaccine in the inoculation drive and prioritising be...

Hopeful moment Sir — The Drug Controller General of India’s approval for ZyCoV-D, the three-dose DNA vaccine manufactured by Zydus Cadila, comes as a relief for parents. Children aged 12 ...